http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111892612-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c189eedf29b8d6e547d5b386c2d46c33
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D499-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D507-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D499-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D507-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-46
filingDate 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b04d1435165a701d1427ab58a9204d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1964dad43aceecdc292796146846a26d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a93b53f7ddbf36d1ded9955f6879b82b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a81a73f7f70f37239528ec06942bc584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a613693459107ad5561040afc1737658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e7d56307ae208387ba1af430bcbf108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68d644bf3be45c5a12a484316bab76a5
publicationDate 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111892612-A
titleOfInvention A kind of intermediate isomerate for preparing cefavicin by using penicillin potassium salt as raw material and preparation method thereof
abstract The invention discloses an intermediate isomer for preparing cefavicin by using penicillin potassium salt as a raw material and a preparation method thereof. Add the dehydrated reaction organic solvent to the reaction vessel, then add the intermediate oxide, adjust the temperature to 90-100°C, stir until the solution is clear, add trimethyl phosphite, adjust the vacuum, and control the reaction temperature to be 90-100°C , react until the reaction is complete, cool to below 30°C under nitrogen protection, add organic base to the reaction vessel, and react under nitrogen protection below 30°C to avoid light until the reaction is complete to obtain intermediate isomers. Compared with the existing steps, when the intermediate of the present invention is synthesized, it is prepared by a one-pot method, which reduces the difficulty of operation. Since the stability of the cephalosporin nucleus is poor, the present invention improves the selectivity of the reaction through strict control of the reaction conditions, and finally makes the reaction yield high and the product quality good.
priorityDate 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020008183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9720848-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457754985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452277918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5484735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5742673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453569306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415845908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38103

Total number of triples: 75.